Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,840
-30 (-0.28%)
Apr 29, 2026, 11:24 AM KST
-21.22% (1Y)
| Market Cap | 232.98B |
| Revenue (ttm) | 605.43B |
| Net Income (ttm) | -1.38B |
| Shares Out | 21.43M |
| EPS (ttm) | -87.38 |
| PE Ratio | n/a |
| Forward PE | 16.30 |
| Dividend | 250.00 (2.29%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 11,115 |
| Average Volume | 30,533 |
| Open | 10,830 |
| Previous Close | 10,870 |
| Day's Range | 10,730 - 10,950 |
| 52-Week Range | 9,670 - 14,700 |
| Beta | 0.26 |
| RSI | 56.51 |
| Earnings Date | May 15, 2026 |